BioCentury
ARTICLE | Company News

Pluristem Life Systems Inc., Stem Cell Innovations deal

February 26, 2007 8:00 AM UTC

SCLL received rights to market PLRS's PLX-1 and 3-D PluriX bioreactor in Asia, excluding Japan. PLX-1 is an adjuvant cell therapy based on placenta-expanded mesenchymal cells. PLX-1 is currently in pr...